Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:THOR

Synthorx (THOR) Stock Price, News & Analysis

Synthorx logo

About Synthorx Stock (NASDAQ:THOR)

Advanced Chart

Key Stats

Today's Range
$67.99
$67.99
50-Day Range
$67.99
$67.99
52-Week Range
$11.05
$71.90
Volume
N/A
Average Volume
474,507 shs
Market Capitalization
$2.20 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive THOR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Synthorx and its competitors with MarketBeat's FREE daily newsletter.

THOR Stock News Headlines

​9 AI Stocks Set to Soar Amid U.S.-China Trade Tensions
The escalating U.S.-China trade tensions are reshaping the AI landscape. Companies like Nvidia are facing significant revenue hits with the U.S. imposing new export restrictions on advanced AI chips to China. This shift opens doors for U.S.-based AI companies poised to fill the gap.
Biosimilar Interleukins Global Market Report 2023
See More Headlines

THOR Stock Analysis - Frequently Asked Questions

Synthorx, Inc. (NASDAQ:THOR) issued its quarterly earnings data on Tuesday, November, 5th. The medical instruments supplier reported ($0.38) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.50) by $0.12.

Synthorx (THOR) raised $100 million in an IPO on Friday, December 7th 2018. The company issued 9,100,000 shares at a price of $10.00-$12.00 per share. Jefferies, Leerink Partners and Evercore ISI acted as the underwriters for the IPO and H.C. Wainwright & Co. was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that Synthorx investors own include Pfizer (PFE), NVIDIA (NVDA), Gilead Sciences (GILD), Meta Platforms (META), Alibaba Group (BABA), Tesla (TSLA) and Salesforce (CRM).

Company Calendar

Last Earnings
11/05/2019
Today
7/09/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
Health Care Equipment
Current Symbol
NASDAQ:THOR
CIK
350907
Fax
N/A
Employees
48
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$56.61 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$6.72 per share
Price / Book
10.12

Miscellaneous

Free Float
N/A
Market Cap
$2.20 billion
Optionable
Not Optionable
Beta
N/A
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

This page (NASDAQ:THOR) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners